[HTML][HTML] Blood purification in severe and critical COVID-19 patients: a case series of 5 patients

H Chen, L Zhang, W Zhang, L Liu, Z Dai… - Frontiers in Public …, 2021 - frontiersin.org
Objective: The ongoing coronavirus disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a worldwide pandemic …

[HTML][HTML] COVID-19 patients require prolonged extracorporeal membrane oxygenation support for survival compared with non-COVID-19 patients

M Russ, M Menk, JA Graw, V Skrypnikov… - Critical Care …, 2022 - journals.lww.com
OBJECTIVES: To investigate the ICU survival of venovenous extracorporeal membrane
oxygenation (ECMO) patients suffering from COVID-19–related acute respiratory distress …

[HTML][HTML] Comparison of blood and blood product transfusion in COVID-19 and Non-COVID-19 patients requiring extracorporeal membrane oxygenation for severe …

MC Fernando, T Hayes, M Besser, F Falter - Journal of Clinical Medicine, 2023 - mdpi.com
COVID-19 has resulted in an exponential increase in patients with severe respiratory failure
requiring extracorporeal membrane oxygenation (ECMO). Patients on ECMO regularly …

[HTML][HTML] Retrospective study shows that early administration of convalescent plasma in hospitalized COVID‐19 patients may have a positive effect on disease …

I Birschmann, K von Bargen, M Teune… - Health Science …, 2022 - ncbi.nlm.nih.gov
2. METHODS In this retrospective study, a total of 52 patients hospitalized between April 1,
2020 and February 28, 2021 and with SARS‐CoV‐2 infection confirmed by RT‐PCR were …

[HTML][HTML] Impact of plasmapheresis on severe COVID-19

G Fonseca-González, M Alamilla-Sánchez… - Scientific Reports, 2023 - nature.com
The clinical course of COVID-19 may show severe presentation, potentially involving
dynamic cytokine storms and T cell lymphopenia, which are leading causes of death in …

Apheresis and COVID-19 in intensive care unit (ICU)

Z Xanthi, P Vasiliki, A Stavros - Transfusion and Apheresis Science, 2022 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is a contagious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first known case was …

Organ replacement therapy and life-supporting treatment modalities in critically ill COVID-19 patients

M Berhés, Á Fábián, I László, T Végh, C Molnár… - Orvosi …, 2020 - europepmc.org
In critically ill COVID-19 patients, the failure of the cardiorespiratory system can be due to
one of the following:(1) cytokine storm, haemophagocytosis–septic shock,(2) unmanageable …

Therapeutic plasma exchange in adult critically ill patients with life-threatening SARS-CoV-2 disease: a pilot study

F Faqihi, A Alharthy, M Alodat, DJ Kutsogiannis… - Journal of critical …, 2020 - Elsevier
Purpose We investigated the effect of therapeutic plasma exchange (TPE) on life-
threatening COVID-19; presenting as acute respiratory distress syndrome (ARDS) plus multi …

[HTML][HTML] Improvement of clinical outcome, laboratory findings and inflammatory cytokines levels using plasmapheresis therapy in severe COVID-19 cases

M Hassaniazad, MS Vahedi, HR Samimagham… - Respiratory …, 2021 - Elsevier
Introduction Cytokine storm is one of the consequences of the severe forms of COVID-19
due to excessive immune response. In this study, we investigated the therapeutic effect of …

Recovery from respiratory failure after 49-day extracorporeal membrane oxygenation support in a critically ill patient with COVID-19: case report

F Guo, C Deng, T Shi, Y Yan - European Heart Journal-Case …, 2021 - academic.oup.com
Background Respiratory failure is a life-threatening complication of coronavirus disease
2019 (COVID-19)-related acute respiratory distress syndrome. Extracorporeal membrane …